Inventor · disambiguated record
Rutger Folmer
Also filed as: FOLMER RUTGER · FOLMER RUTGER HENK ADRIAAN
3 granted patents·7 pending applications·1 citations·filing 2019–2025
49Inventor score
Files withTOLREMO THERAPEUTICS AG4IMMUNEERING CORP3MIRONID LTD1REMYND N V1VOLASTRA THERAPEUTICS INC1
Top patents by PatentIndex Score
10 records- 0177US11780849B2Imino sulfanone inhibitors of ENPP1VOLASTRA THERAPEUTICS INC·Filed 2021·Granted Oct 10, 2023·1 cites·10 claims
- 0261US2025388604A1Compounds and Their Use as PDE4 ActivatorsMIRONID LTD·Filed 2023·Application pending·0 cites
- 0358US12351566B2MEK inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2021·Granted Jul 8, 2025·0 cites·21 claims
- 0457US2025270180A1Mek inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2025·Application pending·0 cites
- 0556US2025388592A1(aza)spiroheptane derivatives for the treatment of neurodegenerative disordersREMYND N V·Filed 2023·Application pending·0 cites
- 0651US2025179057A1Mek immune oncology inhibitors and therapeutic uses thereofIMMUNEERING CORP·Filed 2023·Application pending·0 cites
- 0751US2025289818A1Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of cancerTOLREMO THERAPEUTICS AG·Filed 2025·Application pending·0 cites
- 0850US2024327394A1Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancerTOLREMO THERAPEUTICS AG·Filed 2022·Application pending·0 cites
- 0950US2023067929A1Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of cancerTOLREMO THERAPEUTICS AG·Filed 2019·Application pending·0 cites
- 1047US12478624B2Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancerTOLREMO THERAPEUTICS AG·Filed 2020·Granted Nov 25, 2025·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Rutger Folmer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →